Fig. 6

The figure represents the multifaceted role of miR-579-3p in BRAF-mutant metastatic melanoma. A The circulating levels of miR-579-3p can be easily determined in liquid biopsies and are able to predict response to targeted therapy in patients. B Lipid nanoparticles (LNPs) delivering miR-579-3p can prolong the efficacy of targeted therapies in melanoma xenograft models